GOFF BRIAN (EVP & Chief Commercial Officer) received a stock award from ALEXION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 7/16/2021ACC: 0000899866-21-000051
Officer· EVP & Chief Commercial Officer
Since Feb 2019
+60.14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60.14K acquired
Non-Derivative Transactions2
Common Stock, par value $.0001 per share
Direct
Shares
+30.64K
Price / share
—
Trade value
—
% of position
33.8%
7/14/2021
90.69K→121.33K
Common Stock, par value $.0001 per share
Direct
Shares
+29.50K
Price / share
—
Trade value
—
% of position
24.3%
7/14/2021
121.33K→150.83K
Total
Net shares
+60.14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share Direct | 7/14/2021 | A · Award | +30.64K | — | — | 33.8% | 90.69K | 121.33K |
| Common Stock, par value $.0001 per share Direct | 7/14/2021 | A · Award | +29.50K | — | — | 24.3% | 121.33K | 150.83K |
| Total | +60.14K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported